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Background: Germline mutations in APC and AXIN2 are both associated with colon neoplasia as well as anomalous
dental development. We tested the hypothesis that congenitally missing teeth may occur more commonly in
individuals diagnosed with colorectal cancer than in individuals without this diagnosis.
Methods: Via a survey conducted on 1636 individuals with colorectal cancer (CRC) and 2788 individuals with no
colorectal cancer from the Colon Cancer Family Registry, self-reported information on congenitally missing teeth was
collected. The frequency of missing teeth between cases and controls was compared using Pearson’s chi-squared test
or Fisher’s exact test.
Results: 4.8% of cases and 5.7% of controls reported having at least one missing tooth (p = 0.20). When we stratified
by recruitment site, gender, and mutation status where available, frequency of missing teeth was not statistically
significantly different between cases and controls.
Conclusions: This study did not provide support for there being a general predisposition to missing teeth among a
large cohort of CRC patients. The study neither addresses nor excludes the possibility, however, that individuals
presenting with notable hypodontia/oligodontia might still have an increased risk for colorectal neoplasia.
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Teeth are formed from neural crest-derived mesenchyme
and epithelium of the first branchial arch and part of the
frontonasal process [1,2]. The main proteins involved in
development of dentition belong to one of five signaling
pathways including Notch, bone morphogenetic protein,
fibroblast growth factor, sonic hedgehog, and Wingless/
integration (WNT).
A Finnish family was described in 2004 [3] in which a
nonsense mutation in axis inhibition protein 2 (AXIN2)
was found to co-segregate with an oligodontia (severe
tooth agenesis) phenotype. Further characterization of
the family identified adenomatous colorectal polyps and
cancer as part of the phenotype. A second family, also in
Finland, with the same AXIN2 mutation was reported by
Renkonen et al. [4] as part of their study of 29 polyposis
families in which no adenomatous polyposis coli (APC)
mutation was found. The APC gene, mutations of which
cause Familial Adenomatous Polyposis, is a key component* Correspondence: nlindor@mayo.edu
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unless otherwise stated.of the WNT-signaling pathway. Like AXIN2, APC muta-
tions can be associated with dental anomalies including
missing or supernumerary teeth [5].
The reported association between AXIN2 variants,
colorectal cancer, and tooth agenesis suggests that these
conditions may be associated. However, no large-scale
studies of colorectal cancer (CRC) patients have been
conducted to assess a general association between colo-
rectal neoplasia and missing teeth. The aim of this study
was to determine if congenitally missing teeth may occur
more commonly in individuals diagnosed with colorectal
cancer than in individuals without this diagnosis. If so,
then questioning people about missing teeth might help
identify those at increased risk for colorectal cancer. In
this study, we surveyed participants of the Colon Cancer
Family Registry (C-CFR) for self-reported missing per-
manent teeth and compared findings with unaffected
relatives and controls. We also assayed for the presence
of AXIN2 mutations in the only two probands presen-
ting with colon cancer and tooth agenesis, and in family
members with tooth agenesis but not cancer.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Participants in this study were recruited through the
C-CFR, a National Institutes of Health-supported con-
sortium established to provide resources for the inter-
disciplinary study of the etiology of colon cancer and
identification of at-risk populations who may benefit from
translational research and current therapeutic strategies.
The consortium consists of six research centers: Fred
Hutchinson Cancer Research Center, Seattle, Washington;
University of Hawaii Cancer Research Center, Honolulu,
Hawaii; Mayo Clinic, Rochester, Minnesota; The University
of Southern California Consortium, Los Angeles, California;
Cancer Care Ontario, Ontario, Canada; and the University
of Melbourne, Victoria, Australia. Detailed information
about the C-CFR is described by Newcomb et al. [6]. This
study included only CRC families from the Mayo Clinic
and Toronto C-CFR sites, recruited both through the
clinics and from population-based sources. After enroll-
ment of the proband, recruitment invitation was extended
to adult first- and second-degree relatives and in some
families beyond that. Both Mayo Clinic and Cancer Care
Ontario systematically oversampled for multiplex families
and young-onset probands, but no information about den-
tition was known prior to enrollment. For C-CFR study
participants with CRC, tumor characterization is routinely
conducted to determine DNA mismatch repair status, and
if abnormal, further testing is conducted for germline
mutations in DNA mismatch repair genes [7]. Genetic test-
ing for mutations in MUTYH is also standard for C-CFR
probands [8]. Results of this molecular characterization
were not used as inclusion or exclusion criteria for this
study.
Standardized protocols were used to collect family
history, risk factor information, and biospecimens. For
this study, two questions were added to the 5- or 10-
year follow-up survey. The first asked if the participant
had any permanent teeth that never formed, not count-
ing wisdom teeth. If they answered yes, the second
question asked how many teeth were missing. Cases
were defined as probands and relatives who had been
diagnosed with colorectal cancer. Controls were defined
as relatives and spouses who had never been diagnosed
with any cancer. All study participants provided written in-
formed consent and institutional review board approval
was obtained at each center.
Five of the CRC cases with a missing tooth reported one
or more relatives with missing teeth (none of those rela-
tives had CRC). On the two Mayo probands and their five
relatives, we performed direct sequencing of all AXIN2
exons and exon-intron boundaries to look for mutations
(DNA not available on the three multiplex Toronto fa-
milies). Sequencing reactions were performed according
to established protocols. Primer sequences and reaction
conditions are available upon request.The frequency of missing teeth between cases and
controls were compared using Pearson’s chi-squared test
or Fisher’s exact test. The comparisons were also made
stratified by the recruitment site (Cancer Care Ontario,
Mayo Clinic), gender (male, female), and germline muta-
tion status (MLH1, MSH2, MSH6, PMS2n MUTYH).
Note: the germline status of these genes was available in
the C-CFR. These genes are not suspected of being in-
volved with dental formation but were included in a
stratified analysis just to be certain they were not con-
tributing anything to the phenotype. Genetic testing for
APC and AXIN2 were not conducted systematically in
the C-CFR so were not part of this study design nor
stratified analyses. However, sequencing of AXIN2 was
conducted on two individuals who did have a colon can-
cer/missing teeth phenotype, and so this was reported,
though it was not a primary aim of the study. All
statistical analyses were conducted using STATA 12.1
[StataCorp. Stata Statistical Software: Release 12. College
Station, TX: StataCorp LP; 2011].
Results
Of a total of 1809 cases (1596 probands and 213 rela-
tives), we excluded 173 (148 probands and 25 relatives)
who did not provide missing teeth information. Of a
total of 3005 controls (2737 relatives and 268 spouses),
we excluded 217 (207 relatives and 10 spouses) who did
not provide missing teeth information. The remaining
1636 cases (1448 probands and 188 relatives) and 2788
controls (2530 relatives and 258 spouses) entered into
the analysis. Table 1 shows the baseline characteristics of
the cases versus the controls.
We observed that 4.8% of cases and 5.7% of controls
reported having at least one missing tooth (Table 1), and
there was no statistical evidence of difference between
them (p = 0.20). When we stratified by recruitment site,
gender, and mutation status where available, frequency
of missing teeth was not statistically significantly differ-
ent between cases and controls. Women were reported
to have more missing teeth than men in both cases (odds
ratio [OR] = 2.21; 95% confidence interval [CI] = 1.30-3.93;
p = 0.002) and controls (OR = 1.56; 95% CI = 1.09-2.27;
p = 0.01; Table 2).
We looked to see if there were families in which mul-
tiple individuals reported missing teeth, and there were
only a few. There were five CRC cases with a missing
tooth reported in which one or more relatives had miss-
ing teeth (none of those relatives had CRC); eight of the
CRC cases who themselves did not have missing teeth
had two or more relatives with missing teeth; and of the
CRC cases who did report one or more missing teeth, 24
had no other relatives surveyed in this study. All other
probands had no reported missing teeth and 0-1 rela-
tives with missing teeth.
Table 1 Self-reported missing teeth in study participants
Cases* Controls†
(n = 1636) (n = 2788)
Missing teeth
No 1558 2630
Yes 78 (4.8%) 158 (5.7%)
Number of missing teeth
1 24 57
2 22 54
3 2 6
4 7 9
5 0 2
≥6 1 6
unknown 22 24
*Cases had diagnosis of colorectal cancer.
†Controls had no colorectal cancers.
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five relatives with hypodontia revealed the presence of a
common P50S missense variant in exon 10 of the AXIN2
gene in one of the two probands with colon cancer and
tooth agenesis, in four siblings with tooth agenesis but
not colon cancer, and in one unaffected sibling (no colon
cancer and no tooth agenesis). No AXIN2 mutations
were found in the second proband.Table 2 Frequency of missing teeth between cases and
controls
Cases Controls p value
n/N (%) n/N (%)
Total 78/1636 (4.8%) 158/2788 (5.7%) 0.20
Recruitment site
Ontario 51/928 (5.5%) 88/1484 (5.9%) 0.66
Mayo Clinic 27/708 (3.8%) 70/1304 (5.4%) 0.12
Gender
Male 20/695 (2.9%) 47/1094 (4.3%) 0.12
Female 58/941 (6.2%) 111/1694 (6.6%) 0.70
Mutation status*
MLH1 1/63 (1.6%) 2/19 (10.5%) 0.13
MSH2 6/72 (8.3%) 3/35 (8.6%) 0.99
MSH6 0/8 (0%) 2/5 (40%) 0.13
PMS2 0/10 (0%) 0/6 (0%) NA
All MMR genes 7/153 (4.6%) 7/65 (10.8%) 0.13
MUTYH 0/23 (0%) 1/24 (4.2%) 0.99
n = number of study participants with missing teeth.
N = total number of study participants.
*The germline status of these genes was available in the Colon Cancer Family
Registry. These genes are not suspected of being involved with dental
formation but were included in a stratified analysis just to be certain they
were not contributing to the phenotype.Discussion
Prompted by the discovery of an association between
colon polyps and cancer with tooth agenesis, several
investigators have examined the potential for a colon
neoplasia predisposition and WNT-signaling pathways
genes from different perspectives. Peterlongo et al. [9]
searched for AXIN2 mutations in 82 familial (CRC fam-
ilies in which other syndromes had been ruled out. They
found 29 DNA variants, none of which appeared likely
to be pathogenic. Mostowska et al. [10] studied 55
Caucasians from Poland with missing teeth (nearly half
had true oligodontia) and observed an increased risk of
tooth agenesis in individuals carrying the AXIN2 c.956 +
16G allele (OR = 2.94; 95% CI = 1.10-7.82; p = 0.03) and
the c.2062 T allele (OR = 4.01; 95% CI = 1.56-10.30; p =
0.02). Lejeune et al. [11] studied 39 patients with multiple
adenomas and no APC mutation nor DNA mismatch
repair defect and found one person with two variants of un-
certain significance in AXIN2. Callahan et al. [12] studied
167 individuals with tooth agenesis (majority with only 1-2
teeth missing) and found an association between missing
incisors and one of three intragenic polymorphisms in the
AXIN2 gene. The most significant association was for a
missense mutation in exon 10 (P50S, rs2240308) with a
p-value of 0.037, and they concluded that their work pro-
vided further evidence that AXIN2 contributes to tooth
agenesis. This suggested relationship between AXIN2 and
tooth agenesis also led to findings that AXIN2 gene variants
may have a role in cleft lip/palate in multiple populations
[13], with and without the presence of tooth agenesis as
part of the clinical phenotype [14]. In a study of families
with cleft lip and/or palate, a family history of cancer was
reported more often than in control families with higher
rates of specific cancer types including colon (p < 0.001)
[15]. Most recently, Marvin et al. [16] reported a novel pro-
tein truncating AXIN2 mutation (c.1989G >A; p.Try663X)
that segregated in an autosomal-dominant pattern with
colonic polyposis, gastric polyps, and a mild ectodermal
dysplasia phenotype.
This current study was conducted to evaluate self-
reported missing teeth as a potential marker for predis-
position to CRC. We did not find that participants with
CRC were any more likely to report missing teeth than
their unaffected relatives or unrelated controls. To not
form one or more of the normal 20 deciduous teeth and
32 permanent teeth is said to be one of the most common
developmental anomalies in humans.
Approximately 20% of humans will have at least one
missing third molar (“wisdom teeth”) and 3-10% have fail-
ure of formation for one or more of the other permanent
teeth (reviewed in Nieminen 2009 reference). Both our
CRC cases and the unaffected control group reported fre-
quencies of missing teeth consistent with this range. The
term hypodontia is a term used to describe only a few
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anomaly with six or more missing teeth. True oligodontia
is quite rare, affecting 0.1-0.2% of the population [17].
Seven of 4244 (0.16%) individuals in this study reported
true oligodontia, also in keeping with the literature; thus,
the self-reported nature of this study is a limitation but the
reported values are consistent with other studies. In general,
failure to form one or more permanent teeth (excluding
third molars) is reported to be about twice as common in
females as in males, and again, our data reflect that trend.
Overall, this study did not provide support for there being
a general predisposition to missing teeth among a large co-
hort of CRC patients. It does not, however, rule out the
likelihood that a small percentage of individuals may have
germline variants in genes that predisposed them to both
CRC and missing teeth. It may be that if a population of
people with oligodontia were surveyed for cancer risks,
one might still find that this is a marker for colorectal
neoplasia but that oligodontia is so uncommon as to not
be appreciable in a study of the size we conducted.
Of note, tooth agenesis is a common, multifactorial birth
defect and can be sporadic or familial (inherited as domi-
nant, recessive, or X-linked), and present variable pene-
trance in affected families [17]. It also presents variable
prevalence rates among different ethnic backgrounds;
therefore, the use of family-based studies may allow detec-
tion of segregation between different phenotypes and im-
prove the likelihood of gene discovery in affected families.
AXIN2 mutations have been regarded as causative for the
segregation of CRC and oligodontia in a Finnish family [3].
In the present study, we sequenced the AXIN2 gene locus
in two probands presenting colon cancer and tooth agene-
sis (although the milder form, hypodontia) and having rela-
tives with tooth agenesis. We found a common missense
variant (P50S, rs2240308; minor allele frequency approxi-
mately 0.35 in North America) in one of the probands. Five
of this proband’s siblings including an unaffected sister
(without tooth agenesis) also presented the variant. The
AXIN2 P50S variant is unlikely related to the familial tooth
agenesis or the colon cancer phenotype in this family.
Additional, and yet possibly unknown genes, may be con-
tributing to the segregation of these two different clinical
phenotypes. Additional studies are underway to molecularly
characterize the relevant genes in this population, with
special attention to those few families that did report famil-
ial hypo- or oligodontia.
Conclusion
This study did not provide support for there being a
general predisposition to missing teeth among a large
cohort of CRC patients. The study does not exclude
the possibility, however, that individuals presenting
with notable hypodontia/oligodontia might still have
an increased risk for colorectal neoplasia.Abbreviations
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